Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a ctDNA Methylation-based Dual-target Test for the Detection of Colorectal Cancer: a Multicenter Clinical Study

NCT05508503 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT05508503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05508503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a ctDNA Methylation-based Dual-target Test for the Detection of Colorectal Cancer: a Multicenter Clinical Study
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Completed
Start date
October 21, 2022
Completion date
August 11, 2023
Enrollment
1,378 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma, colorectal cancer